Tag: Motley Fool

On Thursday, the S&P/ASX 200 Index (ASX: XJO) was sold off and sank notably lower. The benchmark index fell 1.65% to 7,064.5 points.

Will the market be able to bounce back from this on Friday and end the week on a high? Here are five things to watch:

ASX 200 expected to fall

The Australian share market looks set to end the week in the red following another poor night on Wall Street. According to the latest SPI futures, the ASX 200 is expected to open the day 9 points or 0.1% lower this morning. In the US, the Dow Jones was down 0.75%, the S&P 500 dropped 0.6%, and the Nasdaq fell 0.25%.

Oil prices rise

Energy producers including Beach Energy Ltd (ASX: BPT) and Woodside Petroleum Limited (ASX: WPL) could have a good finish to the week after oil prices pushed higher. According to Bloomberg, the WTI crude oil price is up 1.55% to US$111.30 a barrel and the Brent crude oil price is up 2% to US$111.32 a barrel. In other news, Woodside shareholders have voted in favour of merging with the petroleum operations of BHP Group Ltd (ASX: BHP).

Healius update

The Healius Ltd (ASX: HLS) share price will be on watch today. This morning the healthcare company is holding its strategy day. At the event, Healius is likely to provide an update on its performance during the second half of FY 2022. Investors will no doubt be keen to see how the shift to RAT testing has impacted its COVID testing volumes.

Gold price rises

Gold miners Newcrest Mining Ltd (ASX: NCM) and St Barbara Ltd (ASX: SBM) could have a good finish to the week after the gold price rose overnight. According to CNBC, the spot gold price is up 1.35% to US$1,840.1 an ounce. Traders were buying the precious metal after the US dollar and US bond yields retreated.

Aristocrat shares named as a buy

The team at Goldman Sachs believe the Aristocrat Leisure Limited (ASX: ALL) share price remains good value following the gaming technology company’s half-year update. According to a note, the broker has retained its buy rating and $43.00 price target. It said: “Stay Buy, noting >27% upside to our unchanged TP, balance sheet strength/optionality, capital management supporting the stock, strong operational momentum and valuation support.”

The post 5 things to watch on the ASX 200 on Friday appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX shares today
• New or old energy: Have oil producers bested ASX lithium shares?
• Top brokers name 3 ASX dividend shares to buy today
• Has the ANZ dividend been growing?
• 2 ASX dividend shares rated as buys by experts amid inflation volatility

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/DIzk3GR

If you’re interested in buying some exchange traded funds (ETFs), then the two listed below could be worth considering.

Here’s what you need to know about these ETFs:

BetaShares Global Cybersecurity ETF (ASX: HACK)

The first ETF for investors to consider is the BetaShares Global Cybersecurity ETF. This ETF gives investors exposure to the growing cybersecurity sector.

With more and more infrastructure and services shifting to the cloud, online threats are only getting greater. This is expected to lead to demand for cybersecurity services continuing to increase for years to come.

This will be good news for the shares included in the BetaShares Global Cybersecurity ETF, which include the leaders in the global cybersecurity sector. These are the likes of Accenture, Cisco, Cloudflare, Crowdstrike, and Okta.

VanEck Vectors MSCI World ex Australia Quality ETF (ASX: QUAL)

Another ETF that could be worth a look is the VanEck Vectors MSCI World ex Australia Quality ETF.

This ETF gives investors exposure to a high quality group of shares from share markets across the world. And as it excludes Australian shares, it could be a good option for investors that are already overweight with ASX investments.

VanEck notes that to be included in the fund, companies need to pass certain criteria. This includes having low leverage, high earnings growth rates, and high returns on equity. Among its holdings are giants such as Apple, Microsoft, Nike, and Nvidia.

Felicity Thomas from Shaw and Partners is a fan of this ETF. She recent told Livewire: “[F]or me, it’s actually a buy. With rising interest rates and the war that’s going on in Europe, I actually think it’s important to invest in quality companies with high revenue growth and a solid balance sheet, which QUAL provides.”

The post 2 high quality ETFs for ASX investors to buy appeared first on The Motley Fool Australia.

More reading

• Here are 2 ASX-listed ETFs that might be able to fend off inflation
• Here are 2 quality ETFs that are now a lot cheaper
• Here are 2 ETFs delivering breakneck ASX performance
• 2 excellent ETFs for investors to buy in May
• 3 top ETFs for ASX investors to buy and hold for 10 years

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BETA CYBER ETF UNITS. The Motley Fool Australia has positions in and has recommended BETA CYBER ETF UNITS. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/LvPRJaG

Fortunately for growth investors, there are plenty of shares on the Australian share market with strong long term growth potential.

Two such shares that have been named as buys are named below. Here’s why analysts are positive on them:

NextDC Ltd (ASX: NXT)

The first growth share that could be a buy is NextDC. It is a leading data centre operator which appears well-placed to benefit from the structural shift to the cloud.

Especially given the company’s world class network of centres across key locations throughout Australia.

In addition, NextDC has its eyes on edge centres (regional data centres) and the Asia market. The latter has seen the company open up offices in Singapore and Tokyo. These markets could provide NEXTDC with a long growth runway.

Citi is a fan and is forecasting strong earnings growth over the coming years. As a result, it currently has a buy rating and $14.55 price target on NEXTDC’s shares.

Xero Limited (ASX: XRO)

Another ASX growth to look at is Xero. It is a cloud-based accounting solution platform provider to small and medium sized businesses globally.

Xero has been growing at a rapid rate in recent years and continued this trend in FY 2022. Earlier this month, the company released its full-year results and revealed a 29% increase in revenue to NZ$1.1 billion and a 28% jump in annualised monthly recurring revenue (AMRR) to NZ$1.2 billion. This was underpinned by a 19% increase in total subscribers to 3.3 million thanks to growth in all markets.

Positively, Xero’s subscriber count is still well short of its total addressable market of 45 million subscribers globally. This and its plan to monetise its growing user base give it a very long growth runway in the 2020s.

Goldman Sachs is bullish on Xero and believes it has a multi-decade growth runway. Its analysts currently have a buy rating and $118.00 price target on its shares.

The post Analysts name 2 ASX growth shares to buy now appeared first on The Motley Fool Australia.

More reading

• What’s happening with ASX 200 tech shares today?
• Why this ASX 200 share is my biggest personal holding: fund manager
• 2 beaten down ASX tech shares analysts say have major upside potential
• Leading brokers name 3 ASX shares to sell today
• Why this fund manager is backing Xero shares for the rest of 2022

Motley Fool contributor James Mickleboro owns NEXTDC Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/wWshKlc

Today, the S&P/ASX 200 Index (ASX: XJO) followed Wall Street off the edge of a cliff. Investors exited retailers amid concerns of earnings pressure from inflation after a disappointing first quarter result from Target. At the end of the session, the benchmark index finished 1.65% lower at 7,064.5 points.

To the disappointment of shareholders, there were minimal glimmers of green in the Australian share market today. The sole sector managing to catch a bid and stay above the red sea was healthcare. Meanwhile, the rest of the index felt the pain of pessimism on Thursday.

In a rare sight to see, consumer staples fell more than tech. The sector, which is typically considered more stable, was trodden on amid concerns the broader retail sector could be adversely affected by inflation.

However, the question is: which shares delivered the biggest returns to investors on the ASX today? Here are the top ten stocks that came through for investors:

Top 10 ASX shares countdown today

Looking at the top 200 listed companies, Aristocrat Leisure Ltd (ASX: ALL) was the biggest gainer today. Shares in the gaming technology company jumped 6.74% after publishing cracking half year results and announcing a $500 million share buyback. Find out more about Aristocrat Leisure here.

The next best performing ASX share across the market today was Evolution Mining Ltd (ASX: EVN). The gold miner moved 2.04% ahead as the gold price inched higher in the last 24 hours. Uncover the latest Evolution Mining details here.

Today’s top 10 biggest gains were made in these ASX shares:

ASX-listed company	Share price	Price change
Aristocrat Leisure Ltd (ASX: ALL)	$33.73	6.74%
Evolution Mining Ltd (ASX: EVN)	$3.50	2.04%
Genesis Energy Ltd (ASX: GNE)	$2.46	1.65%
Northern Star Resources Ltd (ASX: NST)	$8.71	1.63%
Webjet Ltd (ASX: WEB)	$5.87	1.38%
Pro Medicus Ltd (ASX: PME)	$40.76	1.32%
Skycity Entertainment Group Ltd (ASX: SKC)	$2.54	1.20%
Meridian Energy Ltd (ASX: MEZ)	$4.21	0.96%
Challenger Ltd (ASX: CGF)	$7.47	0.81%
Ebos Group Ltd (ASX: EBO)	$35.28	0.77%

Our top 10 ASX shares today countdown is a recurring end-of-day summary to ensure you know which companies were making big moves on the day. Check-in at Fool.com.au after the market has closed during weekdays to see which stocks make the countdown.

The post Here are the top 10 ASX shares today appeared first on The Motley Fool Australia.

More reading

• Has the ANZ dividend been growing?
• These 3 shares are topping the ASX 200 volume charts on Thursday
• 3 ASX 200 shares defying today’s carnage to climb higher
• Why Aristocrat, Arafura, Calix, and Strike Energy shares are charging higher
• Zip share price dives to yet another multi-year low

Motley Fool contributor Mitchell Lawler has positions in Pro Medicus Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus Ltd. The Motley Fool Australia has positions in and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Challenger Limited and Webjet Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/wGJ9bUs

The Imugene Limited (ASX: IMU) share price took off today despite the company’s silence.

However, today’s gains might have been a belated reaction to the news the company announced to the ASX yesterday.

As of Thursday’s close, the Imugene share price is 20 cents. That’s 17.65% higher than it was at the end of Wednesday’s session. It reached an intraday high of 21.5 cents today, representing a 26.47% gain.

For context, the S&P/ASX 200 Index (ASX: XJO) finished the day 1.6% lower.

Let’s take a closer look at the latest news from the clinical-stage immuno-oncology company.

Did this drive the Imugene share price today?

The Imugene share price leapt higher today as the healthcare sector outperformed.

In fact, the stock’s sector, represented by the S&P/ASX 200 Health Care Index (ASX: XHJ), was the only one in the green today. It closed 0.1% higher and was, perhaps unsurprisingly, led by Imugene.

The stock’s movement comes one day after the company announced the first patient has been dosed in its phase 1 clinical trial of its cancer-killing oncolytic virus CF33-hNIS, Vaxinia.

The trial is the first time the virus has come up against tumours in humans.

It has previously been shown to shrink colon, lung, breast, ovarian, and pancreatic cancer tumours in preclinical laboratory and animal models.

The study is being run in partnership with City of Hope. That’s the cancer treatment and research organisation that developed the virus. The study aims to recruit 100 patients across Australia and the United States.

The Imugene share price gained 3% yesterday. Though, the stock has notably underperformed throughout 2022 so far.

It is 53% lower than it was at the start of 2022. It has also fallen 50% since this time last year.

The post Imugene share price surges 18% to lead the ASX 200 on Thursday appeared first on The Motley Fool Australia.

More reading

• 2 ASX All Ordinaries shares having a cracking day, despite the carnage
• ASX 200 midday update: Aristocrat’s earnings beat, Webjet flops, retailers smashed
• Here’s why the Imugene share price just got a boost
• Why Imugene, Integrated Research, Monash IVF, and Step One shares are sinking
• ASX 200 midday update: Brambles rockets, Goodman upgrades guidance

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/hx9Miks

It’s been a good year for commodities in general with prices reaching all-time highs. Both ASX lithium shares and oil producers have benefited from the prevailing supply and demand dynamics, making investors wealthy in the process.

Oddly enough, both commodities could be considered in competition with each other: oil being the old energy, and lithium the new. However, recent events have demonstrated there can be room for both to perform.

But which segment of energising ASX shares has outdone the other in the past 12 months?

Compare the pair

First of all, it can be difficult to compare entire segments of the stock market with each other. The timeframe and the sample of companies being weighed against each other can be manipulated to show different findings.

So, it’s important to note that this comparison looks at the performance over the last year with a handful of the largest lithium and oil companies.

A little hypothesis to start with… the performance of companies operating in commodities tends to be linked to the price of the underlying commodity itself. Based on this, we could assume the companies that have likely performed the best are the ones with the better performing commodity.

According to Trading Economics, the price of crude oil is up approximately 78% year on year, now hovering around US$110 per barrel. This is a substantial one-year price increase for crude oil.

However, the increase in the price of oil looks paltry compared to the approximate 410% increase in lithium carbonate prices. The expectation of future demand outstripping supply for the electric battery commodity led to an explosion in the lithium price.

But, how does this comparison play out in terms of ASX lithium and oil shares?

As shown in the chart above, both new and old energy shares have performed well in the last year. The least impressive return on our list is oil and gas giant Santos Ltd (ASX: STO). Whereas, the home run of the bunch is lithium explorer Liontown Resources Limited (ASX: LTR).

Are ASX lithium shares the victors?

The referenced chart indicates the top three best performers for the last 12 months are lithium shares. These are Liontown Resources, Pilbara Minerals Ltd (ASX: PLS), and Allkem Ltd (ASX: AKE). Impressively, all three delivered returns in excess of 100%.

Comparatively, oil producers such as Woodside Petroleum Limited (ASX: WPL) and Beach Energy Ltd (ASX: BPT) only conjured up gains of 33% and 28% respectively.

It is worth noting that many of the superior performing ASX lithium shares came off a lower base. In other words, it is easier to grow 100% when the company’s market capitalisation is $2 billion instead of $20 billion.

Nonetheless, it looks like lithium shares were the better bet for investors over the last year.

The post New or old energy: Have oil producers bested ASX lithium shares? appeared first on The Motley Fool Australia.

More reading

• These 3 shares are topping the ASX 200 volume charts on Thursday
• 5 things to watch on the ASX 200 on Thursday
• What’s dragging on ASX 200 energy shares like Santos today?
• Here are the 3 most heavily traded ASX 200 shares on Wednesday
• ASX 200 energy shares in focus amid frightening global supply crisis

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/rAhyKmD

Fortunately for income investors, there are countless dividend shares for them to choose from on the Australian share market.

But with so many options, it can be hard to decide which ones to buy. To narrow things down, I have picked out three ASX dividend shares brokers think investors should buy:

BHP Group Ltd (ASX: BHP)

According to a note out of Macquarie, its analysts have retained their outperform rating and $60.00 price target on this mining giant’s shares. This follows the company’s presentation at a major industry conference this week. Macquarie came away from the event feeling confident in the Big Australian’s outlook, highlighting its potash plans and iron ore expansion options. As for dividends, Macquarie expects the miner to pay fully franked dividends of $5.01 per share in FY 2022 and $3.67 per share in FY 2023. Based on the current BHP share price of $46.23, this will mean yields of 10.8% and 7.9%, respectively.

Healius Ltd (ASX: HLS)

Another note out of Macquarie reveals that its analysts have retained their outperform rating but trimmed their price target on this healthcare company’s shares to $5.20. The broker remains positive on Healius due to its valuation and expectation for a recovery in pathology volumes in FY 2023. In respect to dividends, Macquarie has pencilled in fully franked dividends of 17.3 cents per share in FY 2022 and 18 cents per share in FY 2023. Based on the current Healius share price of $4.19, this will mean yields of 4.1% and 4.3%, respectively.

Mineral Resources Limited (ASX: MIN)

Analysts at Credit Suisse have commenced coverage on this mining and mining services company’s shares with an outperform rating and $73.00 price target. Credit Suisse is positive on Mineral Resources due to its exposure to iron ore and particularly lithium. It also expects its pipeline of mining projects to support its growth in the coming years. And while the broker is only forecasting an 86 cents per share dividend in FY 2022, it expects a big increase to $4.41 per share in FY 2023. Based on the latest Mineral Resources share price of $59.33 this will mean fully franked yields of 1.45% and 7.4%, respectively.

The post Top brokers name 3 ASX dividend shares to buy today appeared first on The Motley Fool Australia.

More reading

• 2 ASX dividend shares rated as buys by experts amid inflation volatility
• Own BHP shares? Here’s what you need to know about the commodity predicted to be bigger than petroleum for the mining giant
• Why is the BHP share price charging 3% higher today?
• Top brokers name 3 ASX shares to buy today
• Macquarie reveals 2 sectors where bargain ASX shares still exist

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/D7bOgdz

The Little Green Pharma Ltd (ASX: LGP) share price avoided the market selloff on Thursday.

The vertically integrated medicinal cannabis company’s shares jumped 23% to 40 cents.

Why did the Little Green Pharma share price rocket higher?

Investors were bidding the Little Green Pharma share price today after the cannabis company released a positive update.

According to the release, the company has entered into a two-and-a-half year take-or-pay contract with new distribution partner, Four 20 Pharma, for the exclusive supply of the high-THC (25% THC) SMS strain into Germany.

The release notes that the agreement represents a minimum take-or-payment commitment of at least $7.5 million over 30 months. It also includes the payment of a development fee to help defray strain development costs.

Management isn’t resting on its laurels, though. The company revealed that it now intends to seek similar agreements for other new strains, as well as roll out the SMS strain into other jurisdictions.

Management commentary

Little Green Pharma’s Chief Executive Officer, Fleta Solomon, was pleased with the agreement. Solomon commented:

We are very excited by our new SMS strain as well as the opportunity to be partnering with Four 20 Pharma, one of the largest medicinal cannabis operators in Germany and with a highly successful track record of supplying its 420 Natural brand cannabis products into the German market.

The Agreement represents another significant milestone in LGP’s continued growth of its Danish Facility, as well as an exciting development in LGP’s supply processes that promises to dramatically shorten LGP’s supply timelines for future key strains.

We look forward to working closely with Four 20 Pharma to bring this highly-prospective new strain to market as quickly as possible.

Despite today’s strong gain, the Little Green Pharma share price has still lost a third of its value in 2022.

The post Why did the Little Green Pharma share price flame 23% higher today? appeared first on The Motley Fool Australia.

More reading

• Top brokers name 3 ASX dividend shares to buy today
• Has the ANZ dividend been growing?
• Why was the Pendal share price in freefall on Thursday?
• 2 ASX dividend shares rated as buys by experts amid inflation volatility
• 2 ASX All Ordinaries shares having a cracking day, despite the carnage

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/PIoXCgA

As an ASX 200 banking share, the Australia and New Zealand Banking Group Ltd (ASX: ANZ) share price arguably has some expectations to fill when it comes to paying dividends.

The big four ASX banks are staples of ASX investors’ share portfolios, and have been for decades. A large part of this fondness for bank shares is the banks’ proclivity to pay large, fully franked dividend payments.

On the surface, ANZ shares seem to be filling this implicit obligation with gusto today. As the bank currently stands, it has a fully franked dividend yield of 5.69% (or 8.13% grossed-up with the full franking) on the table.

But has the ANZ dividend been growing? After all, a growing dividend is a lot more valuable to an investor over a long period of time than a stagnant one.

Well, let’s look at the facts, shall we?

Is the ANZ dividend a grower?

ANZ’s current dividend yield comes from the bank’s two most recent dividend payments.

The first of these was the fully franked final dividend of 72 cents per share that investors saw paid out back in December. The second is the interim dividend of 72 cents per share (again fully franked) that investors will receive on 1 July later this year. ANZ shares traded ex-dividend for this payment on 9 May.

But how do these dividends compare to those investors have received in recent years?

Well, last year’s interim dividend was only worth 70 cents per share. So there has been a 2.86% year-on-year increase there. And last year’s final dividend of 72 cents was an even bigger jump against 2020’s final payment of 35 cents per share.

But that was in the midst of the initial COVID crisis, so arguably this comparison doesn’t count for too much.

Let’s go back to the pre-COVID world of 2019 then. Back in 2019, ANZ paid out two dividends worth 80 cents each. This was a repeat of the dividends that ANZ paid out back in 2018, 2017, and 2016. In 2015 the bank doled out an interim dividend of 86 cents per share and a final dividend of 95 cents.

So yes, the ANZ dividend has increased this year compared to last. But you don’t have to go back too far to see dividends from ANZ shares that were far higher than those on offer today. Make of that what you will.

The post Has the ANZ dividend been growing? appeared first on The Motley Fool Australia.

More reading

• These 3 shares are topping the ASX 200 volume charts on Thursday
• 3 ASX 200 shares defying today’s carnage to climb higher
• Zip share price dives to yet another multi-year low
• ASX 200 midday update: Aristocrat’s earnings beat, Webjet flops, retailers smashed
• These ASX 200 companies just lost market share to a small-cap rival

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/zP2oIid

Pendal Group Ltd (ASX: PDL) shareholders might be wondering why the share price plummeted 7.1% to $4.84 today.

Well, it’s a simple case of the fund manager’s shares going ex-dividend. This means any shares sold today did not carry with them the entitlement to the next dividend payment.

Pendal released its half-year results on 10 May, reporting growth across key financial metrics.

In turn, the board elected to ramp up its interim dividend by 23.5% to eligible investors.

Shareholders eye the Pendal interim dividend

The Pendal share price was in reverse due to the company’s shares trading ex-dividend today.

Typically, the ex-dividend date is one business day before the record date. Investors who wanted to receive the dividend needed to buy Pendal shares before the ex-dividend date.

Historically, when a company reaches its ex-dividend day, its shares tend to fall in proportion to the dividend paid out. This is because investors tend to sell off the company’s shares after securing the dividend.

When can shareholders expect to be paid?

Shareholders will receive a payment of 21 cents per share on 1 July. The dividend is partially franked at 10%, which means investors will receive some tax credits to help reduce their annual income tax liability.

While Pendal does have a dividend reinvestment plan (DRP), the board decided to keep it inactive for the interim dividend.

Management noted that the latest dividend is within the group’s annual payout ratio of 80% to 95% of underlying profit after tax.

Pendal share price summary

Since the beginning of 2022, Pendal shares have lost 16.2% on the back of weakened ASX investor sentiment. The S&P/ASX 200 Financials Index (ASX: XFJ) is down 2.6% over the same time frame.

Pendal shares reached a 52-week low of $4.04 in March before rebounding despite inflationary movements and market volatility.

Based on today’s price, Pendal commands a market capitalisation of almost $2 billion. It has a trailing dividend yield of 8%.

The post Why was the Pendal share price in freefall on Thursday? appeared first on The Motley Fool Australia.

More reading

• Why Nufarm, Pendal, Wesfarmers, and Westpac shares are sinking
• 5 things to watch on the ASX 200 on Wednesday
• Why GrainCorp, Link, NAB, and Pendal shares are sinking today
• Time is running out to secure dividends from these 3 ASX 200 shares
• Why EOS, Pendal, PolyNovo and Xero shares are charging higher

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/PBIAc0t